Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP) Peptide
ALOX5AP
适用: 人
宿主: 兔
BP
-
- 抗原 See all ALOX5AP products
- ALOX5AP (Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP))
- 宿主
- 人
-
资源
- 兔
- 应用范围
- Blocking Peptide (BP)
-
-
- 限制
- 仅限研究用
-
- 储存条件
- -80 °C
-
- 抗原
- ALOX5AP (Arachidonate 5-Lipoxygenase-Activating Protein (ALOX5AP))
- 别名
- fj65d02 Peptide, zgc:63982 Peptide, wu:fj65d02 Peptide, flap Peptide, al5ap Peptide, Alox5ap Peptide, ALOX5AP Peptide, Flap Peptide, FLAP Peptide, arachidonate 5-lipoxygenase-activating protein Peptide, arachidonate 5-lipoxygenase activating protein Peptide, alox5ap Peptide, ALOX5AP Peptide, Alox5ap Peptide
- 背景
- Seems to be required for the activation of 5-LO (5-lipoxygenase). Could play an essential role in the transfer of arachidonic acid to 5-LO. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes. Genetic variations in FLAP may be a cause of susceptibility to ischemic stroke [MIM:601367], also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.
-
You are here:
